DE.NETZWERK-UNIVERSITAETSMEDIZIN.EBM-CPG\Study eligibility criteria for Systemic corticosteroids plus standard care vs. standard care (plus/minus placebo)

Clinical Practice Guidelines (CPG) on EBMonFHIR
0.8.0-snapshot - ci-build

Clinical Practice Guidelines (CPG) on EBMonFHIR - Local Development build (v0.8.0-snapshot) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

Example EvidenceVariable: Study eligibility criteria for Systemic corticosteroids plus standard care vs. standard care (plus/minus placebo)

Active as of 2024-05-15

Generated Narrative: EvidenceVariable

ResourceEvidenceVariable "StudyEligibilityCriteriaSystemicCorticosteroidsCOVID19"

Profile: Study Eligibility Criteria

url: https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/EvidenceVariable/StudyEligibilityCriteriaSystemicCorticosteroidsCOVID19

name: StudyEligibilityCriteriaSystemicCorticosteroidsCOVID19

status: active

date: 2024-05-15 06:48:35+0000

characteristic
DefinitionByTypeAndValues
- Type Value[x]
* Clinical finding (finding) (SNOWMED CT#404684003) Disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder) (SNOWMED CT#840539006)